期刊文献+

浅表性膀胱癌术后复发和进展影响因素分析 被引量:5

Analysis of the prognostic factors affecting postoperative recurrence and progression in patients with superficial bladder transitional cell carcinoma
原文传递
导出
摘要 目的探讨影响浅表性膀胱移行细胞癌术后复发和进展的主要因素。方法初次收治浅表性膀胱移行细胞癌患者共150例,获得随访120例,对可能影响肿瘤复发和进展的因素(如病理特点、治疗方案等)进行Cox回归分析。结果平均随访84.7个月。3、5年的复发率分别为27.5%和36.7%,影响复发的主要因素是肿瘤病理分级、TNM分期、肿瘤数量、肿瘤复发情况,而肿瘤病理分级、TNM分期和肿瘤复发情况是肿瘤复发的独立危险因素。3、5年的进展率分别为9.2%和17.5%,影响进展的主要因素是肿瘤病理分级、TNM分期、肿瘤数量、肿瘤复发情况,而肿瘤病理分级是肿瘤进展的独立危险因素。结论肿瘤病理分级、TNM分期、肿瘤数量、肿瘤复发情况均是影响浅表性膀胱移行细胞癌术后复发和进展的独立危险因素。 Objective To evaluate the prognostic factors affecting postoperative recurrence and progression in patients with superficial bladder transitional cell carcinoma(SBTCC). Methods From 2000 to 2004,150 patients with SBTCC were treated, of which 120 patients were followed up. The possible prognostic factors including clinical and pathological figures were analyzed by Cox's proportional hazard model in these patients. Results The mean follow-up period was 84. 7 months. The recurrence rates at 3-year,5-year were 27.5% and 36.7% respectively. The main variables affecting recurrence were histological grades ,tumor stage, tumor number and recurring tumor, and the first three were the independent risk factors. The progression rates at 3-year,5-year were 9.2% and 17.5%. The main variables affecting progression were histological grade, tumor stage, tumor number and recurring tumor, and the first one was the independent risk factor. Conclusion The main variables affecting progression were histological grade, tumor stage,tumor number and recurring tumor,and the first one were the independent risk factor.
出处 《中国基层医药》 CAS 2009年第10期1743-1744,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 膀胱肿瘤 肿瘤复发 预后 Urinary bladder neoplasms Neoplasms recurrence,local Prognosis
  • 相关文献

参考文献6

  • 1Flechon A, Droz JP. Chemotherapy practices and perspectives in invasive bladder cancer. Expert Rev Anticancer Ther, 2006, 6 (10) :1473-1482.
  • 2Yu ILl, Stein JP, Cai J, et al. Superficial ( pT2a ) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical eystectomy. J Urol,2006,176(2) :493-499.
  • 3Nieder AM, Simon MA, Kim SS, et al. Radical cystectomy after bacillus Calmette Guerin for high-risk T. ,Tt and carcinoma in situ: defining the risk of initial bladder preservation. Urology,2006,67 (4) :737-741.
  • 4陆鸿海,杨堃.147例表浅性膀胱癌预后因素分析[J].肿瘤防治杂志,2001,8(1):64-65. 被引量:8
  • 5张军,曾荔,李贵忠,杨新宇,夏同礼,那彦群,郭应禄.膀胱移行细胞癌T1期复发的多因素分析[J].中华肿瘤杂志,2003,25(5):475-477. 被引量:18
  • 6Denkbas EB, Zdemyr N, Ozturk E. Mitomycin-C-loaded alginate carriers for bladder cancer chemotherapy: in vivo studies. Bioact Compat Polym ,2004,19( 1 ) :33-44.

二级参考文献18

  • 1[1]Kurth-K H. Intravesical chemotherapy for superficial bladder tumors category Ta/T1: Who should be treated and how [J]. semin Urol Oncol, 1996,14(1S11) :30 - 35.
  • 2[2]Zieger K,Woff H,Olsen P R,et al. Long-term survival of patients with bladder tumors:the siginificance of risk factors[J]. Br J Urol, 1998,82(5) :667 - 672.
  • 3[3]Holmangs, Hedelin H, Anderstrom C, et al. The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study[J] .J Urol, 1997,157(3) :800 - 803.
  • 4[4]Zieger K, Wolf H, Olsen PR, et al. Long-term folow-up of noninvasive bladder tumors (stage Ta): recurrence and progression [J]. Br J Urol,2000,85 (7): 824 - 828.
  • 5[5]Rodriguez FM, Toniolo GC, BayarriJ S, et al. Mulultivarite analysis of the prognostic factors of primary superficial Bladder cancer [J]. J Urol,2000,163(1) :73 - 78.
  • 6[6]Freeman JA, Ersig D, Stein JP,et al. Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstnuotion [J]. Cancer 1995,76: 833 - 837.
  • 7[7]Gohji K, Nomi M, Okamoto M, et al. Conservative therapy for stage T1b,Grade 3 transitional cell carcinoma of the bladder[J]. Urology,1999,53(2) :308 - 313.
  • 8[8]Herr HW.The value of a second transurethral resection in evaluating patients with bladder tumors [J]. J Urol, 1999,162 (1): 74 - 76.
  • 9Serth J, Kuczyk MA, Bokemeyer C, et al. p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder. Br J Cancer, 1995. 71 : 201-205.
  • 10Lipponen PK, Eskelinen MJ. Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer. J Cancer Res Clin Oncol, 1995, 121 : 303-306.

共引文献23

同被引文献49

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部